Edition:
India

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

6.80USD
19 Jan 2018
Change (% chg)

$0.20 (+3.03%)
Prev Close
$6.60
Open
$6.75
Day's High
$6.87
Day's Low
$6.50
Volume
32,945
Avg. Vol
11,096
52-wk High
$8.14
52-wk Low
$2.81

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
FY 2016 Dec '16 1.25 -0.410
Sep '16 1.15 -0.468
Jun '16 1.37 -0.461
Mar '16 0.86 -0.398
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 1.13 2.00 0.00 --
Quarter Ending Jun-18 3 1.14 2.03 0.00 --
Year Ending Dec-18 5 2.37 5.00 0.00 0.50
Earnings (per share)
Quarter Ending Mar-18 3 -0.49 -0.43 -0.61 --
Quarter Ending Jun-18 3 -0.45 -0.44 -0.47 --
Year Ending Dec-18 5 -2.10 -1.98 -2.33 -2.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.36%
# of Holders: 40
Total Shares Held: 10,711,478
3 Mo. Net Change: 218,740
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 1
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.